To encourage responsible and
appropriate use of ICDs, CMS issued a Decision Memo for Implantable
Defibrillators on January 27, 2005, indicating that ICDs will be
covered for primary prevention of sudden cardiac death if the
beneficiary is enrolled in either an FDA-approved category B IDE
clinical trial (42 DFR ?405.201), a trial under the CMS Clinical
Trial Policy (NCD Manual ?310.1) or a qualifying prospective data
collection system (either a practical clinical trial or prospective
systematic data collection, which is sometimes referred to as a
registry).
US Code:
42
USC 1395y Name of Law: Exclusions from Coverage and Medicare as
a Secondary Payer
The data collection form has
changed significantly to delete data elements and fields that were
found to be no longer applicable. While some additional data
elements were added due to the collection of important information
regarding device lead placement, many fields also were greatly
improved by better field descriptors and definitions. The majority
of the increased time necessary to complete the data form is due to
the additional data elements related to device lead placement.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.